We are live on ! Find out more
FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
1-Year Est. Return 44.84%
This Fund
S&P 500
This Quarter Est. Return
-26.13%
1 Year Est. Return
+44.84%
3 Year Est. Return
-66.21%
5 Year Est. Return
-36.36%
10 Year Est. Return
AUM
$29.2M
AUM Growth
-$10.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXG icon
1
10x Genomics
TXG
$5.55B
$29.2M 100%
708,528

Similar funds

Foresite Capital Management II's Q3 2023 Portfolio in Review

As of Q3 2023, Foresite Capital Management II held 1 position worth $29.2M, down 26% from $39.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. Foresite Capital Management II opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management II's ten largest holdings make up 100% of its $29.2M portfolio in Q3 2023.
  • Foresite Capital Management II opened 0 new positions and closed 0 in Q3 2023.
  • Foresite Capital Management II's portfolio value fell 26% quarter-over-quarter to $29.2M.

Based on Foresite Capital Management II's 13F filing for Q3 2023, filed 13 Nov 2023.